Search results
3 Stocks That Can Help You to Get Richer in 2025 and Beyond | The Motley Fool
The Motley Fool· 3 days agoPer the research of Wharton professor Jeremy Siegel, stocks have outperformed bonds, gold, and the...
Biotech stocks are rising alongside bird flu fears
Semafor via Yahoo Finance· 4 days agoVaccine makers, including Moderna, BioNTech, and CureVac, all saw double-digit stock increases, as investors bet they could cash in on a public health...
Moderna Options Trading: A Deep Dive into Market Sentiment - Moderna (NASDAQ:MRNA)
Benzinga· 4 days agoThe firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States ...
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 5 days agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks· 4 days agoFree Report) and Pfizer (PFE Quick QuotePFE - Free Report) to set up a possible vaccine program aimed at preventing the spread of the H5N1 virus, also known as bird flu, in ...
AstraZeneca aims increase its annual revenue by 75% in its post-COVID era
Quartz· 6 days agoCambridge, U.K.-based pharmacuetical giant AstraZeneca announced an ambitious sales goal for the end of this decade, just as it pulls it COVID-19
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 6 days agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
AOL· 3 days agoNovavax's updated vaccine targets a variant called JN.1, which is in line with European recommendations. The European Union's regulator ...
COVID Is Rising in Bay Area Wastewater Again. Why? | KQED
KQED· 4 days agoNow, health officials must rely on a combination of wastewater data and hospital deaths of patients...
Robeco Institutional Asset Management B.V. Decreases Stake in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 6 days ago(NASDAQ:MRNA – Free Report) by 51.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 68,889 shares of the company’s stock ...